Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02392403 |
Date of registration:
|
13/03/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Clinical Investigation of the Nucleus® CI532 Cochlear Implant
|
Scientific title:
|
Clinical Investigation of the Nucleus® CI532 Cochlear Implant |
Date of first enrolment:
|
April 2015 |
Target sample size:
|
45 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02392403 |
Study type:
|
Interventional |
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Australia
|
France
|
Germany
|
Spain
| | | | |
Contacts
|
Name:
|
Chris J James, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Cochlear |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Eighteen years of age or older at the time of implantation
- Conventional candidate for cochlear implantation with a perimodiolar electrode array
according to local criteria (excepting the exclusion criteria that follow)
- Native speaker in the local language used to assess clinical performance
Exclusion Criteria:
- Evidence of hearing loss prior to 5 years of age
- Prior cochlear implantation; i.e. having a cochlear implant in the contralateral ear,
or previously implanted in either ear
- Medical or psychological conditions that contraindicate undergoing general anaesthesia
or surgery
- Ossification, malformation or any other cochlear anomaly, such as common cavity, that
might prevent complete insertion of the electrode array, as confirmed by medical
examination
- Hearing impairment due to lesion or neuropathy of the acoustic nerve, VIII nerve or
central auditory pathway
- Active middle-ear infection
- Tympanic membrane perforation
- Unrealistic expectations on the part of the subject, regarding the possible benefits,
risks, and limitations that are inherent to the surgical procedure(s) and prosthetic
devices
- Unwillingness or inability of the candidate to comply with all investigational
requirements such as undergoing a post-operative digital volume tomography/ConeBeam
scan
- Patients with existing Cerebral Spinal Fluid shunts or drains, existing perilymph
fistula, skull fracture or Cerebral Spinal Fluid leak
- Patients with recurrent episodes of bacterial meningitis
- Pregnancy or breast-feeding
- Known allergies to components of the implant
- Wearing other active implants with known interference with cochlear implants
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Hearing Loss
|
Intervention(s)
|
Device: Nucleus CI532 cochlear implant
|
Primary Outcome(s)
|
Scalar Position of Electrode Array Determined With Computer Tomography (CT) Scan
[Time Frame: up to one month post-surgery]
|
Secondary Outcome(s)
|
Change From Baseline in Air-conduction Pure-tone Hearing Thresholds Via an Audiogram at 6 Months
[Time Frame: baseline and 6 months post activation]
|
Change From Baseline in Speech Recognition in Quiet and Noise at 6 Months
[Time Frame: baseline and 6 months post activation]
|
Patient Reported Benefit in Health Status Assessed Via Glasgow Benefit Inventory Questionnaire
[Time Frame: 6 months post activation]
|
Number of Adverse Events at Surgery
[Time Frame: at time of surgery]
|
Number of Adverse Events Post Surgery to 6 Months Post-activation
[Time Frame: post surgery to 6 months post-activation]
|
Array Proximity to the Modiolus Measured Using the Wrapping Factor
[Time Frame: up to one month post-surgery]
|
Change From Baseline in Hearing Ability Assessed Via Speech Spatial Hearing Qualities Questionnaire at 6 Months
[Time Frame: baseline and 6 months post activation]
|
Surgeon Questionnaire on Implant Surgery
[Time Frame: at time of surgery]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
|